Several other institutional investors have also recently added to or reduced their stakes in CVS. Illinois-based Dearborn Prtnrs Ltd Liability has invested 0.83% in CVS Health Corporation (NYSE:CVS). 7,150 are owned by S&Co. The firm owned 31,241 shares of the pharmacy operator's stock after purchasing an additional 600 shares during the quarter. The legal version of this report can be read at https://www.fairfieldcurrent.com/news/2019/01/18/cvs-health-corp-cvs-position-increased-by-first-american-trust-fsb.html. Hayek Kallen Investment Management now owns 13,567 shares of the pharmacy operator's stock valued at $844,000 after purchasing an additional 641 shares during the last quarter.
Shares of CVS rose almost 3 percent before the opening bell Friday. Rehmann Capital Advisory Group now owns 11,599 shares of the pharmacy operator's stock valued at $913,000 after purchasing an additional 389 shares in the last quarter. The firm owned 58,694 shares of the pharmacy operator's stock after buying an additional 29,078 shares during the quarter.
Shares of NYSE CVS opened at $63.92 on Thursday. CVS Health Corp has a 1-year low of $60.14 and a 1-year high of $83.88. It has change of 0.05, from 2018Q2's 1.07. Mercer Advisers Inc reported 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS).
CVS Health Corporation (NYSE:CVS)'s quarterly earnings will be reported on February, 14., Zacks reports. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. Analysts sees 23.70 % EPS growth this quarter. During the same period in the previous year, the business earned $1.50 EPS. The business's revenue for the quarter was up 2.4% on a year-over-year basis. On average, analysts expect that CVS Health Corp will post 7.02 EPS for the current year. Axa invested in 0.17% or 573,163 shares. The ex-dividend date is Thursday, January 24th. This represents a $2.00 annualized dividend and a dividend yield of 3.05%. CVS Health's payout ratio is 33.90%. 166,368 shares were sold by MERLO LARRY J, worth $11.49 million on Tuesday, January 8. Following the completion of the sale, the insider now directly owns 496,577 shares of the company's stock, valued at $34,283,676.08. The stock was sold at an average price of $80.13, for a total value of $2,015,990.67.
Australian Open - Dominant Rafa Nadal roars past Tomas Berdych into last eight
Collins, 25, was the more aggressive player throughout and finished with a 29-6 edge in total winners. Berdych was upset with Nadal taking too long after going up 4-3 as well as the serve clock going off.
More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Benzinga.com which released: "Raymond James: CVS (NYSE:CVS) A Strong Buy Despite Pricing Headwinds - Benzinga" on January 15, 2019, also Seekingalpha.com with their article: "Walmart to exit CVS drugstore network - Seeking Alpha" published on January 15, 2019, Seekingalpha.com published: "Molina renews PBM contract with CVS Caremark - Seeking Alpha" on January 03, 2019. The disclosure for this sale can be found here. Brennan Troyen A had sold 14,229 shares worth $1.17M. Insiders own 0.53% of the company's stock.
Several analysts have recently issued reports on CVS shares. Goldman Sachs Group restated a "neutral" rating and set a $87.00 target price on shares of CVS Health in a research report on Thursday, November 29th.
Research professionals at UBS has Buy rating and has target price of $75 on CVS's shares. They set an "outperform" rating and a $89.00 target price for the company. (NYSE:CVS) has 6 ratings reports on Jan 18, 2019 according to StockzIntelligence.
Total analysts of 6 have positions in CVS Health (NYSE:CVS) as follows: 4 rated it a "Buy", 0 with "Sell" and 2 with "Hold".